Diethylamine

Diethylamine

SCHEMBL2151568

CCNCC.O=C(O)C12CC1CCCCCCCCCN1CCCC1CN2

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ SIGMAR1 Q99720 5/20 0.32
▸ CHRM5 P08912 2/20 0.32
▸ CHRM1 P11229 2/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2151647 0.90 HTR6 (0.39) MEN1KMT2AHTR6SIGMAR1CHRM5
Hydrochloric Acid SCHEMBL2151722 0.89 HTR6 (0.38) MEN1KMT2AHTR6SIGMAR1CHRM5
SCHEMBL2009518 0.79 HTR6 (0.38) MEN1KMT2AHTR6SIGMAR1CHRM5
Hydrochloric Acid SCHEMBL3696745 0.78 HTR6 (0.37) MEN1KMT2AHTR6SIGMAR1CHRM5
SCHEMBL7316779 0.62 SLC6A1 (0.32) MEN1KMT2A
SCHEMBL16058143 0.62 SLC6A1 (0.32) MEN1KMT2A
Acetic Acid SCHEMBL11275843 0.62 MEN1 (0.47) MEN1KMT2ASIGMAR1KDM4EALDH1A1
Bicarbonate SCHEMBL19689366 0.61 L3MBTL3 (0.50) MEN1KMT2AKDM4EALDH1A1
Bicarbonate SCHEMBL11101479 0.61 L3MBTL3 (0.50) MEN1KMT2AKDM4EALDH1A1
SCHEMBL2012120 0.61 L3MBTL3 (0.31) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2340029-A2 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Enanta Pharmaceuticals, Inc. (US) 2011-07-06 — — EP disclosed
WO-2010030359-A2 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARJMACEUTICALS, INC. (US) 2010-03-18 — — WO disclosed
Send feedback